The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

被引:160
|
作者
Zhai, Bing [1 ]
Wu, Cheng [1 ]
Wang, Linqi [1 ]
Sachs, Matthew S. [1 ]
Lin, Xiaorong [1 ]
机构
[1] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
基金
美国国家卫生研究院;
关键词
SEROTONIN REUPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; ANTIFUNGAL ACTIVITY; DRUG DEVELOPMENT; AMPHOTERICIN-B; FLUCONAZOLE; NEOFORMANS; TARGET;
D O I
10.1128/AAC.00212-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic treatment for systemic mycoses is severely hampered by the extremely limited number of antifungals. The difficulty of treatment of fungal infections in the central nervous system is further compounded by the poor central nervous system (CNS) penetration of most antifungals due to the blood-brain barrier. Only a few fungistatic azole drugs, such as fluconazole, show reasonable CNS penetration. Here we demonstrate that sertraline (Zoloft), the most frequently prescribed antidepressant, displays potent antifungal activity against Cryptococcus neoformans, the major causative agent of fungal meningitis. In in vitro assays, this neurotropic drug is fungicidal to all natural Cryptococcus isolates tested at clinically relevant concentrations. Furthermore, sertraline interacts synergistically or additively with fluconazole against Cryptococcus. Importantly, consistent with our in vitro observations, sertraline used alone reduces the brain fungal burden at an efficacy comparable to that of fluconazole in a murine model of systemic cryptococcosis. It works synergistically with fluconazole in reducing the fungal burden in brain, kidney, and spleen. In contrast to its potency against Cryptococcus, sertraline is less effective against strains of Candida species and its interactions with fluconazole against Candida strains are often antagonistic. Therefore, our data suggest the unique application of sertraline against cryptococcosis. To understand the antifungal mechanisms of sertraline, we screened a whole-genome deletion collection of Saccharomyces cerevisiae for altered sertraline susceptibility. Gene ontology analyses of selected mutations suggest that sertraline perturbs translation. In vitro translation assays using fungal cell extracts show that sertraline inhibits protein synthesis. Taken together, our findings indicate the potential of adopting this antidepressant in treating cryptococcal meningitis.
引用
收藏
页码:3758 / 3766
页数:9
相关论文
共 50 条
  • [31] Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections
    Parvin Askari
    Masoud Yousefi
    Mohsen Foadoddini
    Alireza Neshani
    Mahdi Aganj
    Nasim Lotfi
    Aref Movaqar
    Kiarash Ghazvini
    Mohammad Hasan Namaei
    Current Microbiology, 2022, 79
  • [32] Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis
    Johnson, Hadley
    Guenther, Jana
    Adler, Brandon L.
    Yu, JiaDe
    CUTIS, 2023, 111 (02): : 92 - 105
  • [33] Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders
    Almikhlafi, Mohannad A. A.
    Karami, Mohammed M. M.
    Jana, Ankit
    Alqurashi, Thamer M. M.
    Majrashi, Mohammed
    Alghamdi, Badrah S. S.
    Ashraf, Ghulam Md.
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (05) : 1165 - 1183
  • [34] REAC Reparative Treatment: A Promising Therapeutic Option for Alcoholic Cirrhosis of the Liver
    de Jesus Maues Pereira, Lizomar
    Pereira, Jose Alfredo Coelho
    Fontani, Vania
    Rinaldi, Salvatore
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (12):
  • [35] Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
    Reitter, S.
    Bauer, F.
    Jaeger, G.
    Linkesch, W.
    Langner, S.
    ONKOLOGIE, 2010, 33 : 178 - 179
  • [36] Targeting IAPs in Childhood Acute Lymphoblastic Leukemia A Promising Therapeutic Option?
    Meyer, M.
    Zinngrebe, J.
    Debatin, K-M
    Meyer, L-H
    ANNALS OF HEMATOLOGY, 2017, 96 : S72 - S72
  • [37] Antisense oligonucleotide: A promising therapeutic option to beat COVID-19
    Quemener, Anais M.
    Galibert, Marie-Dominique
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2022, 13 (04)
  • [38] Gene therapy: a therapeutic option for neoplasias, infections and monogenic diseases
    Cavagnari, Brian M.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2011, 109 (04): : 326 - 332
  • [39] CYCLOSPORINE - IS IT A PROMISING THERAPEUTIC OPTION OR A WRONG WAY IN CHRONIC INFLAMMATORY BOWEL DISEASES
    FISCHBACH, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1995, 33 (05): : 275 - 276
  • [40] Secondary cytoreductive surgery with HIPEC: a promising therapeutic option for recurrent ovarian cancer
    May, Taymaa
    LANCET ONCOLOGY, 2024, 25 (12): : 1509 - 1511